RESCIFINA, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 8.188
EU - Europa 4.644
AS - Asia 4.097
SA - Sud America 632
AF - Africa 396
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.974
Nazione #
US - Stati Uniti d'America 7.872
SG - Singapore 1.950
IT - Italia 1.829
CN - Cina 1.566
IE - Irlanda 921
UA - Ucraina 624
BR - Brasile 573
DE - Germania 365
CA - Canada 283
CI - Costa d'Avorio 279
KR - Corea 232
RU - Federazione Russa 216
SE - Svezia 159
VN - Vietnam 118
FI - Finlandia 107
GB - Regno Unito 107
SN - Senegal 63
FR - Francia 52
IN - India 51
PL - Polonia 42
ES - Italia 38
CZ - Repubblica Ceca 36
NL - Olanda 36
CH - Svizzera 34
BD - Bangladesh 29
AT - Austria 26
TR - Turchia 24
UZ - Uzbekistan 22
AR - Argentina 19
MX - Messico 18
JP - Giappone 16
ZA - Sudafrica 16
EC - Ecuador 14
GR - Grecia 14
AU - Australia 12
HK - Hong Kong 12
IQ - Iraq 12
LB - Libano 11
NG - Nigeria 11
BE - Belgio 10
PK - Pakistan 10
IL - Israele 8
MA - Marocco 8
CO - Colombia 7
LT - Lituania 7
TN - Tunisia 6
VE - Venezuela 6
CL - Cile 5
EG - Egitto 5
AZ - Azerbaigian 4
BG - Bulgaria 4
JM - Giamaica 4
KZ - Kazakistan 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EU - Europa 3
IR - Iran 3
JO - Giordania 3
NP - Nepal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
LU - Lussemburgo 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
ID - Indonesia 1
KG - Kirghizistan 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 17.974
Città #
Santa Clara 1.418
Singapore 1.175
Chandler 1.088
Dublin 922
Jacksonville 732
Chicago 611
Catania 519
Hefei 477
Boardman 411
Abidjan 279
Ashburn 276
Nanjing 256
Lawrence 246
Cambridge 243
Andover 235
Seoul 226
Beijing 207
Toronto 201
Civitanova Marche 168
Houston 144
Bremen 129
Munich 122
Des Moines 114
Wilmington 111
Dallas 109
Dong Ket 90
Los Angeles 88
San Mateo 86
Nanchang 85
Rome 74
Columbus 72
The Dalles 69
Shenyang 67
Naples 66
Dakar 63
Grafing 59
Helsinki 59
Ottawa 58
Council Bluffs 54
Hebei 51
Saint Petersburg 49
Jiaxing 48
São Paulo 44
Changsha 42
Milan 38
Messina 31
Tianjin 31
Brooklyn 30
Palermo 30
Brno 28
Florence 26
Moscow 25
Warsaw 25
Guangzhou 24
Lappeenranta 24
Washington 24
Norwalk 22
San Giovanni la Punta 22
Salerno 20
San Francisco 20
Falls Church 19
Leawood 19
Mascalucia 19
Misterbianco 19
Rio de Janeiro 19
Seattle 19
Padova 17
Tokyo 16
Bari 15
Boston 15
New York 15
Phoenix 15
Turku 15
Belo Horizonte 14
Gravina di Catania 14
Aci Catena 13
Guarulhos 13
Jinan 13
Sala Baganza 13
Stockholm 13
Centro 12
Dhaka 12
Mumbai 12
Ningbo 12
Zhengzhou 12
Den Haag 11
Hangzhou 11
Hanoi 11
Ho Chi Minh City 11
Porto San Giorgio 11
Abuja 10
Bologna 10
Kunming 10
Belpasso 9
Curitiba 9
Groningen 9
Johannesburg 9
Lecce 9
Manchester 9
Pozzallo 9
Totale 12.586
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 222
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 134
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 126
1,3-Dipolar Cycloadditions of Acridine with Nitrile Oxides 124
1,3-Dipolar Cycloadditions of Acridine with Nitrile Oxides 119
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 117
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 116
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 113
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 112
Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules 109
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor 109
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 108
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 107
Isossazolidine: Intermedi per la Sintesi di Piperidine Funzionalizzate 105
Functionalization of single and multi-walled carbon nanotubes with polypropylene glycol decorated pyrrole for the development of doxorubicin nano-conveyors for cancer drug delivery 103
A NEW SYNTHESIS OF STREPTOMYCES LACTONES BY 1,3-DIPOLAR CYCLOADDITION 102
Design of Small Molecules for Oncological and Neurodegenerative Diseases 101
A DFT Rationalization for the Observed Regiochemistry in the Nitrile Oxide Cycloaddition with Anthracene and Acridine 100
4-Nitro-2,1,3-benzoxadiazole derivatives as potential fluorescent sigma receptor probes 100
Crystal morphologies and polymorphs in tolbutamide microcrystalline powder 96
PEGylate porphyrin-gold nanoparticles conjugates as removable pH-sensor nano-probes for acidic environments 96
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells 95
An alpha1-adrenergic receptor ligand repurposed as a potent antiproliferative agent for head and neck squamous cell carcinoma 94
N,O-Eterocicli da cicloaddizioni inter- ed intramolecolari: Utilizzazione nella sintesi di molecole variamente funzionalizzate e nelle sintesi asimmetriche 93
Sigma-2 receptor ligands QSAR model dataset 93
A pseudouridine isoxazolidinyl nucleoside analogue structural analysis: A morphological approach 93
Gemcitabine anticancer activity enhancement by water soluble celecoxib/sulfobutyl ether-β-cyclodextrin inclusion complex 93
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 92
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 91
A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery 90
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 90
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 89
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 89
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 88
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 88
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 87
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 87
Experimental and in silico characterization of a biologically active inosose 87
Fourfold filtered statistical/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products 87
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis 87
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water 87
An intriguing U-shaped molecule as possible ionophore for sensor applications: A computational DFT and NMR study 85
Conversion of oximes to carbonyl compounds by triscetylpyridinium tetrakis(oxodiperoxotungsto) phosphate (PCWP)-mediated oxidation with hydrogen peroxide 85
S2RSLDB: A comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands 85
A general synthetic approach to 5-alkyl-2(5H)furanones via 1,3-dipolar cycloaddition 84
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase 84
Light-Controlled Simultaneous "On Demand" Release of Cytotoxic Combinations for Bimodal Killing of Cancer Cells 84
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 84
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 82
Ammidi dell’acido rosmarinico come potenziali agenti antidiabetici 82
N,O-Nucleosidi fosfonati: nuovi modulatori dell’apoptosi 81
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach 81
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 80
How molecular interactions affect crystal morphology: the case of haloperidol 80
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat 80
Structures and properties in different media of N,N-(diethylcarbamothioyl)furan-2-carboxamide: A ionophore for sensor membranes 79
Synthesis of functionalized polyhedral oligomeric silsesquioxane (POSS) macromers by microwave assisted 1,3-dipolar cycloaddition 79
An asymmetric approach to pyrrolidinone and pyrrolizidinone systems by intramolecular oxime-olefin cycloaddition 79
Use of Microwave Heating in the Synthesis of Heterocycles from Carbohydrates 79
AN INNOVATIVE TOP DOWN APPROACH TO OBTAIN FUNCTIONALIZED GRAPHENE LAYERS 79
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 79
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 79
γ-Cyclodextrins as Supramolecular Reactors for the Three-component Aza-Darzens Reaction in Water 78
Synthesis and characterization of copolycarbonates having azobenzene units in the main chain as an active group for optical logic gate devices 78
Postbiotic Characterization in the Amensalistic Symbiosis and Correlation to the Resilience of Human Microbiota 78
REARRANGEMENT OF ORTHO-ALKYNYL SUBSTITUTED ALPHA-DIAZOACETOPHENONES - CONVERSION TO BETA-NAPHTHOLS VIA ARYLKETENE INTERMEDIATES 77
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 77
3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication 77
Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity 77
Cyclopropanation of 5-Methylene Galactopyranosides by Dihalo-, Ethoxycarbonyl-, and Unsubstituted Carbenes 76
Prevalence of oxetanose forms in the tautomeric equilibrium of β-hydroxy-1,5-dicarbonyl monosaccharides 75
γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water 75
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents 75
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion 75
NOVEL-APPROACH TO THE RING-OPENING OF 4-ISOXAZOLINES - ONE-POT SYNTHESIS OF ALPHA,BETA-ENONES 74
Could N-(diethylcarbamothioyl)benzamide be a Good Ionophore for Sensor Membranes? 74
Chemistry and Biology of Salinomycin and Its Analogues 74
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 74
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 73
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 73
Isoxazolidine analogues of pseudouridine a new class of modified nucleosides 72
Functional hybrid co-crystals of humic substances: a growth forecast 72
Potassium caffeate/caffeic acid co-crystal: the rat race between the catecholic and carboxylic moieties in an atypical co-crystal 72
Intramolecular nitrile oxide cycloaddition (INOC) of substituted amido-oximes 71
Recent developments on rotaxane-based shuttles: an update to 2010 71
Progress in the development of more effective and safer analgesics for pain management 71
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† 71
New anti sars-cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine 71
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity 70
Phosphonated nucleoside analogues 70
A Stereoselective Approach to Isoxazolidinyl Nucleosides 70
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 70
Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase 69
Synthesis of Pyrimidine-Containing 3-Aminobutenolides 69
Diastereoselective Synthesis of N,O-Psiconucleosides via 1,3-Dipolar Cycloadditions 69
Stereoselective Synthesis of 2'-Amino-2',3'-dideoxynucleosides by Nitrone 1,3-Dipolar Cycloaddition: A New Efficient Entry Toward d4T and Its 2-Methyl Analogue 69
Stereoselective Synthesis of Homochiral Annulated Sultams via Intramolecular Cycloaddition Reactions 69
A stereoselective approach to isoxazolidinyl nucleosides 69
Computer-Assisted Design of Peptide-Based Radiotracers 68
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 68
Totale 8.690
Categoria #
all - tutte 71.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.396 0 94 174 47 347 34 146 19 158 21 213 143
2021/20221.892 203 251 40 28 326 21 284 82 161 26 59 411
2022/20233.360 299 174 71 428 286 566 27 498 757 51 126 77
2023/20241.623 112 254 104 101 84 302 52 78 29 51 276 180
2024/20256.514 131 1.120 318 309 1.344 603 302 309 458 640 433 547
2025/20261.689 880 809 0 0 0 0 0 0 0 0 0 0
Totale 18.628